person · Reporting owner
Sterling Denise Marie Brucia
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AirJoule Technologies Corp.AIRJ · Entity 9063 | Director | May 28, 2026 | June 01, 2026 |
| Core Scientific, Inc./txCORZ · Entity 389 | Chief Financial Officer | January 22, 2025 | January 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AirJoule Technologies Corp.
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 25,487 |
Reported balance
After 2026-05-28 transaction · row 1
1 source rowRow 1 · 2026-05-28 · Exercise / conversion · Acquired 25,487 · Balance 25,487 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-28 · Exercise / conversion · Disposed 25,487 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2: The restricted stock units vested on May 28, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 30,227 |
Reported balance
After 2026-05-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-28 · Grant · Acquired 30,227 · Balance 30,227 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3: The restricted stock units vest on the earlier of May 28, 2027 and the date of the next annual shareholders' meeting of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2: The restricted stock units vested on May 28, 2026.
F3: The restricted stock units vest on the earlier of May 28, 2027 and the date of the next annual shareholders' meeting of the Issuer.
Core Scientific, Inc./tx
Report date January 22, 2025 · Filed January 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 440,028 |
Reported balance
After 2025-01-22 transaction · row 1
1 source rowRow 1 · 2025-01-22 · Sale · Disposed 802 · Balance 440,028 F1: Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2026 Filed Jun 1, 2026 23:59 UTC | AirJoule Technologies Corp. AIRJ · Entity 9063 | GrantRestricted Stock Units · Derivative | 30,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-252059 · ownership.xml · derivative · entry 3 Sterling Denise Marie Brucia · CIK 0001922985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,227 Underlying: Class A Common Stock · 30,227 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of May 28, 2027 and the date of the next annual shareholders' meeting of the Issuer. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of May 28, 2027 and the date of the next annual shareholders' meeting of the Issuer. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 23:59 UTC | AirJoule Technologies Corp. AIRJ · Entity 9063 | Exercise / conversionRestricted Stock Units · Derivative | 25,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-252059 · ownership.xml · derivative · entry 2 Sterling Denise Marie Brucia · CIK 0001922985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,487 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vested on May 28, 2026. F2 · derivative.expiration_date: The restricted stock units vested on May 28, 2026. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 23:59 UTC | AirJoule Technologies Corp. AIRJ · Entity 9063 | Exercise / conversionClass A Common Stock | 25,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-252059 · ownership.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2025 Filed Jul 8, 2025 21:26 UTC | AirJoule Technologies Corp. AIRJ · Entity 9063 | GrantRestricted Stock Units · Derivative | 25,487 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-094651 · ownership.xml · derivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,487 Underlying: Class A Common Stock · 25,487 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of July 7, 2026 and the date of the next annual shareholders' meeting of the Issuer. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of July 7, 2026 and the date of the next annual shareholders' meeting of the Issuer. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 02:37 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 802 | $15.64 | $12,544.08 |
DisclosureSEC source: 0000905148-25-000184 · form4.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,028 F1 · kind: Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units. Read SEC document |
| September 05, 2024 Filed Sep 30, 2024 20:28 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 318,613 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-002590 · form4.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,830 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs will vest in full on March 31, 2025, provided that the Reporting Person continues to provide service to the Issuer on such date. This transaction is being reported late due to an inadvertent administrative error. Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 20:45 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 8,752 | $9.41 | $82,373.82 |
DisclosureSEC source: 0000905148-24-002292 · form4.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,217 F1 · kind: Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units. F2 · price: The price reported is a weighted average price of the shares sold on the transaction date by the Issuer's broker to satisfy tax obligations upon the vesting of restricted stock units for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.24 to $9.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:02 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 4,261 | $3.66 | $15,595.26 |
DisclosureSEC source: 0000905148-24-001416 · form4.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,969 F1 · kind: Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.63 to $3.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:10 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Tax withholdingCommon Stock | 16,617 | $3.24 | $53,756.00 |
DisclosureSEC source: 0000905148-24-000795 · form4.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,230 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:10 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock, par value $0.00001 per share | 1,518,472 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-007648 · ownership.xml · nonDerivative · entry 2 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,518,472 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock received their pro rata share of new common stock, par value $0.00001 per share ("New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization). The receipt of the New Common Stock in exchange for Old Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:10 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Disposition to issuerCommon Stock, par value $0.0001 per share | 1,518,472 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-007648 · ownership.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock received their pro rata share of new common stock, par value $0.00001 per share ("New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization). The receipt of the New Common Stock in exchange for Old Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 21:26 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | GrantTranche 2 Warrants · Derivative | 103,080 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0000950170-24-016410 · ownership.xml · derivative · entry 4 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,080 Underlying: Common Stock, par value $0.00001 per share · 103,080 shares Expires 2029-01-23 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), F3 · price: (Continued from footnote 2)and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · price: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. F4 · derivative.exercise_date: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · derivative.exercise_date: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 21:26 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | GrantTranche 1 Warrants · Derivative | 123,696 | Not disclosed Strike: $6.81 | Not disclosed |
DisclosureSEC source: 0000950170-24-016410 · ownership.xml · derivative · entry 3 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,696 Underlying: Common Stock, par value $0.00001 per share · 123,696 shares Expires 2027-01-23 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), F3 · price: (Continued from footnote 2)and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · price: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. F4 · derivative.exercise_date: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · derivative.exercise_date: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 21:26 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock, par value $0.00001 per share | 151,847 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016410 · ownership.xml · nonDerivative · entry 2 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,847 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), F3 · price: (Continued from footnote 2)and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 21:26 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | Disposition to issuerCommon Stock, par value $0.0001 per share | 1,518,472 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016410 · ownership.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), F3 · price: (Continued from footnote 2)and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:56 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046315 · doc4.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518,472 F1 · shares: Represents a restricted stock unit ("RSU") grants. The RSUs vest in four equal annual installments commencing August 15, 2023, provided that the Reporting Person continues to provide service to the Issuer on each vesting date. Read SEC document |
| June 13, 2022 Filed Jun 17, 2022 01:38 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Tax withholdingCommon Stock | 41,580 | $2.02 | $83,991.60 |
DisclosureSEC source: 0001209191-22-037683 · doc4.xml · nonDerivative · entry 2 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,472 F2 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of RSUs. Read SEC document |
| June 13, 2022 Filed Jun 17, 2022 01:38 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 560,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-037683 · doc4.xml · nonDerivative · entry 1 Sterling Denise Marie Brucia · CIK 0001922985 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,052 F1 · shares: Represents restricted stock unit ("RSU") grants. These RSU grants previously were subject to milestone and time vesting. On June 13, 2022, the board of directors of the Issuer removed the milestone requirement. 120,011 of the RSUs vested immediately upon the removal of the milestone requirement; 360,034 will vest in 3 equal installments on July 9, 2022, July 9, 2023 and July 9, 2024; and 80,007 will vest in 4 equal annual installments commencing on January 18, 2023, provided that the Reporting Person continues to provide service to the Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.